• Search Funds
  • Model Portfolios
  • Provider
  • Sector
  • Manager

Search by provider name

Search by sector name

Search by manager name

Search by Risk Level

Sarasin IE Global Equity Opps GBP P Inc

  • Fund Info & charges
  • Performance
  • Fund breakdown
  • Dividend History
Fund Provider Sarasin Funds Management (Ireland) Ltd.
Fund Summary The Fund seeks to provide long-term growth through investment in the shares of companies from across the world.
SEDOL code B8GM8B2
ISIN IE00B8GM8B29
Fund code SGTPI
Managers Alex Hunter, Guy Monson
Manager Tenure 5 years
Morningstar Category Global Large-Cap Blend Equity
IMA Sector Global
Fund Size £165 million
Fund Type OEIC
Management Style Active
Ongoing Charge Figure (OCF) 1%
Cavendish ongoing charge 0.05%
FundsNetwork Service Fee 0.20%
Minimum Initial Investment £25
Minimum Top Up £25
Minimum Monthly Investment £25
Sell Price £45.7510
Buy Price £45.7510
Price Change -2.4997%
Price Date 24th February 2020
Yield 1.58%
Dividend Frequency Semi-Annually
ISA Eligible Yes
SIPP Eligible Yes
Inception Date 11th September 2017
Fund Status OPEN
Alex has been with Sarasin & Partners since 2007, working primarily with the Global Equity franchise and is global equity portfolio manager for the Equity Opportunities fund. Prior to joining Sarasin in 2007, Alex spent 4 years at US hedge fund Arnhold and S. Bleichroeder working with global long only and alternative equity strategies based in both New York and London. From 1996 to 2003 Alex worked at Morgan Stanley as a sell-side equity analyst covering the capital goods sector and subsequently the aerospace sector. Whilst at Morgan Stanley, Alex qualified as a Chartered Financial Analyst (CFA, 1999) and from 1999 to 2003 was consistently ranked, with his team, in the top 3 by surveys such as the Institutional Investor Magazine - being top ranked both in Europe (2002) and globally (2000). Alex is a Fellow of the Institute of Chartered Accountants in England and Wales, holds a BA in Economics and Statistics from the University of Exeter and has taken courses at the London Business School and Harvard Medical School.

3-year Mean Monthly Return: 0.855%

Annual Returns 2019 2018 2017 2016 2015 2014 2013
Fund Performance +24.14% -4.04% +15.82% +21.38% +1.83% +7.90% +20.71%
Benchmark Performance
(Global Large-Cap Blend Equity)
+19.03% -6.71% +12.57% +23.49% +3.36%
Time Period Cumulative Benchmark Performance
(Global Large-Cap Blend Equity)
Fund Compared to Benchmark
1 day -0.99% +3.85% -4.84%
1 week -0.09% +0.63% -0.72%
1 month 0.88% +5.74% -4.86%
3 months 6.74% +5.58% +1.16%
6 months 9.04% +15.43% -6.39%
1 year 20.20% +7.87% +12.34%
3 years 10.62% +9.87% +0.74%
5 years 11.25% +11.31% -0.07%
10 years Currently unavailable Currently unavailable Currently unavailable
YTD 3.53% +0.13% +3.40%
Since inception 12.24% Currently unavailable Currently unavailable

Top 10 shares for this fund

Share Name Country Value
Amgen Inc USA 4.21%
Citigroup Inc USA 3.72%
Taiwan Semiconductor Manufacturing Co Ltd ADR TWN 3.56%
Investor AB B SWE 3.53%
The Home Depot Inc USA 3.41%
Enel SpA ITA 3.33%
JPMorgan Chase & Co USA 3.25%
Marriott International Inc Class A USA 3.24%
Umicore SA BEL 3.16%
Associated British Foods PLC GBR 3.02%
Dividend Date Per share amount Reinvestment Price
2nd January 2020 0.3613 £45.6430
1st July 2019 0.4822 £43.2830
2nd January 2019 0.3954 £37.3920
2nd July 2018 0.4472 £39.6810
2nd January 2018 0.3292 £39.5450
3rd July 2017 0.4422 £37.1650